Máster de Biotecnología, curso académico 2019-2020.--Calificación Final 9,5BACKGROUND: Pancreatic ductal adenocarcinoma (PDA) ranks as the third leading cause of cancer-related deaths among developed countries. New insights into its pathogenesis are urgently needed, seeing that it is highly chemoresistant and immunoresistant. A major factor that contributes to these characteristics is the excessive stroma, which has emerged as a promising target. Galectins are glycan-binding proteins that function both extracellularly and intracellularly and whose expression is altered in several tumors. Few members of the galectin family have been studied in PDA, highlighting the role of Galectin1 (Gal1) and Galectin3 (Gal3), which have been reported to be...
<div><p>Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3–5%. Mutations in...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with a dismal prognosis. However,...
<p>(<i>a</i>) Quantitative analyses of the differentiated phenotype of human PSCs and pancreatic can...
Trabajo presentado en la XVI Reunión de la Asociación Española de Pancreatología, celebrada en Bilba...
Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely lo...
Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely lo...
Pancreatic ductal adenocarcinoma (PDA) is one of the most aggressive tumors; mostly due to its lack ...
International audience: Despite some advances, pancreatic ductal adenocarcinoma (PDAC) remains gener...
Pancreatic cancer is nowadays one of the neoplasms with worst prognosis, so research towards the di...
Background: Galectins are a group of carbohydrate-binding proteins that are involved in neoplastic d...
Altres ajuts: This work was supported by grants from the Spanish Ministerio de Economía y Competitiv...
Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the...
Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the...
Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3-5%. Mutations in K-Ras a...
Background: Galectin-1, a member of carbohydrate-binding proteins with a polyvalent function on tumo...
<div><p>Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3–5%. Mutations in...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with a dismal prognosis. However,...
<p>(<i>a</i>) Quantitative analyses of the differentiated phenotype of human PSCs and pancreatic can...
Trabajo presentado en la XVI Reunión de la Asociación Española de Pancreatología, celebrada en Bilba...
Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely lo...
Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely lo...
Pancreatic ductal adenocarcinoma (PDA) is one of the most aggressive tumors; mostly due to its lack ...
International audience: Despite some advances, pancreatic ductal adenocarcinoma (PDAC) remains gener...
Pancreatic cancer is nowadays one of the neoplasms with worst prognosis, so research towards the di...
Background: Galectins are a group of carbohydrate-binding proteins that are involved in neoplastic d...
Altres ajuts: This work was supported by grants from the Spanish Ministerio de Economía y Competitiv...
Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the...
Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the...
Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3-5%. Mutations in K-Ras a...
Background: Galectin-1, a member of carbohydrate-binding proteins with a polyvalent function on tumo...
<div><p>Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3–5%. Mutations in...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with a dismal prognosis. However,...
<p>(<i>a</i>) Quantitative analyses of the differentiated phenotype of human PSCs and pancreatic can...